Pharma-Bio Serv reports Q2 net income of $0.1M, reversing prior-year loss

Pharma-Bio Serv, Inc.

2025-Q2 EPS reported $0.01 vs consensus $0.03 ▼ miss (-83.7%)

Q2 revenue $2.4M (vs $2.3M YoY); six-month revenue $4.9M (vs $4.8M YoY).
Net income for Q2 and first half $0.1M each, up $0.3M and $0.6M vs prior-year losses.
CEO cites focus on high-margin projects as driver of improved profitability.
No guidance provided; OTCQB ticker PBSV remains unchanged.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.